All eyes on China Grand in Telix Pharma $175m deal
MELBOURNE: ASX-listed oncology business Telix Pharma’s $175 million raise on Thursday had investors ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
